In the annual Congress of Neurological Surgeons, Medtronic (MDT) announced the Conformite Europeen mark and international launch of the PoleStar N30 Surgical MRI system, the latest in neuro oncology surgical solutions. The PoleStar N30 System has been submitted to the U.S. Food and Drug Administration for approval.
Providing real-time imaging in the operating room (OR), the PoleStar Surgical MRI provides surgeons with targeting and navigational accuracy despite the anatomy movement that may occur during a procedure.
With intra-operative imaging information, neurosurgeons have more confidence to achieve maximum tumor resection, while avoiding critical areas of the brain.
For comments and feedback: editorial@rttnews.com